CI

At a glance

ClinicalIndex Comparison Record
Phase 3Recruiting· 225 target
Drug / intervention
Group 1 +2 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05766891
NCT05766891Phase 3RecruitingOn TrackUpdated 3mo ago
CompareCT.gov

Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery

M.D. Anderson Cancer Center·interventional·Posted Mar 13, 2023·Updated Mar 16, 2026

In Brief

A Phase 3 clinical trial evaluating Group 1, Group 2, and 1 other intervention for Breast Cancer. Currently recruiting, targeting 225 participants across 1 site.

Detailed Summary

To hypnosedation alone given before and during surgery on reducing opioid use after surgery compared to standard general anesthesia given alone or with hypnosedation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI), Rising Tide Foundation

Timeline

Phase 3Recruiting
202420252026202720282029
First PostedMar 13, 2023
Enrollment StartOct 12, 2023
Primary CompletionDec 31, 2027
Study CompletionDec 31, 2028
TodayJul 1, 2026
Enrollment to primary: 4.2 yearsPosted 3.3 years agoPrimary completion in 1.5 years

Interventions

Group 1behavioral

Participants will receive hypnosedation will be restarted after arriving in the operating room and will continue for the whole time of surgery

Group 2behavioral

Participants will receive standard general anesthesia and medications to control your pain after arriving in the operating room

Group 3behavioral

Participants will receive standard general anesthesia and medications during surgery to control your pain.